Weed Inc
OTC:BUDZ
Weed Inc
OTC:BUDZ
Price:
0.02
USD
-11.5%
Market Cap:
$2.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Weed Inc
OTC:BUDZ
|
US |
|
E
|
Equals Group PLC
F:2FX
|
UK |
|
Q
|
Quantong Holdings Ltd
HKEX:8316
|
HK |
|
Gelum Resources Ltd
OTC:GMRCF
|
CA |
|
Sanofi SA
LSE:0A2V
|
FR |
|
United Oil & Gas PLC
F:1UO
|
UK |
|
T
|
Top Spring International Holdings Ltd
HKEX:3688
|
HK |
|
Waverunner Capital Inc
OTC:CHMJF
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BUDZ.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BUDZ
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
BUDZ Competitors Multiples
Weed Inc Competitors
Weed Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Weed Inc
OTC:BUDZ
|
2.7m USD | 0 | -3.6 | -4.4 | -4.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.2 | 41.6 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 19.8 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.4 | 16.6 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
